Latorre Ibars, R.; Carvalho-Brugger, S.; Rodríguez Ibáñez, P.; Vallverdú Vidal, M.; Iglesias Moles, S.; Miralbés Torner, M.; Bellés Bellés, A.; Castellano, A.; Campi, D.; Caballero, J.;
et al. Evaluating the Impact of Filmarray Pneumonia Plus Panel in Therapeutic Decision-Making in Critical Patients with Suspected Respiratory Infection. Antibiotics 2026, 15, 521.
https://doi.org/10.3390/antibiotics15050521
AMA Style
Latorre Ibars R, Carvalho-Brugger S, Rodríguez Ibáñez P, Vallverdú Vidal M, Iglesias Moles S, Miralbés Torner M, Bellés Bellés A, Castellano A, Campi D, Caballero J,
et al. Evaluating the Impact of Filmarray Pneumonia Plus Panel in Therapeutic Decision-Making in Critical Patients with Suspected Respiratory Infection. Antibiotics. 2026; 15(5):521.
https://doi.org/10.3390/antibiotics15050521
Chicago/Turabian Style
Latorre Ibars, Rosa, Sulamita Carvalho-Brugger, Paula Rodríguez Ibáñez, Montserrat Vallverdú Vidal, Silvia Iglesias Moles, Mar Miralbés Torner, Alba Bellés Bellés, Andrea Castellano, David Campi, Jesús Caballero,
and et al. 2026. "Evaluating the Impact of Filmarray Pneumonia Plus Panel in Therapeutic Decision-Making in Critical Patients with Suspected Respiratory Infection" Antibiotics 15, no. 5: 521.
https://doi.org/10.3390/antibiotics15050521
APA Style
Latorre Ibars, R., Carvalho-Brugger, S., Rodríguez Ibáñez, P., Vallverdú Vidal, M., Iglesias Moles, S., Miralbés Torner, M., Bellés Bellés, A., Castellano, A., Campi, D., Caballero, J., & Trujillano Cabello, J. J.
(2026). Evaluating the Impact of Filmarray Pneumonia Plus Panel in Therapeutic Decision-Making in Critical Patients with Suspected Respiratory Infection. Antibiotics, 15(5), 521.
https://doi.org/10.3390/antibiotics15050521
